Tissue microarrays for high-throughput profiling in molecular oncology

por Kallioniemi, O-P, Kononen, J, Sauter, G
Publicado 2000

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading.

por Blanco, G., Holli, K., Heikkinen, M., Kallioniemi, O. P., Taskinen, P.
Publicado 1990

Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer.

por Kallioniemi, O. P., Oksa, H., Aaran, R. K., Hietanen, T., Lehtinen, M., Koivula, T.
Publicado 1988

Tumour DNA ploidy as an independent prognostic factor in breast cancer.

por Kallioniemi, O. P., Blanco, G., Alavaikko, M., Hietanen, T., Mattila, J., Lauslahti, K., Koivula, T.
Publicado 1987

c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.

por Haapasalo, H., Hyytinen, E., Sallinen, P., Helin, H., Kallioniemi, O. P., Isola, J.
Publicado 1996

Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy.

por Visakorpi, T., Kallioniemi, O. P., Paronen, I. Y., Isola, J. J., Heikkinen, A. I., Koivula, T. A.
Publicado 1991

Molecular cytogenetic analysis of 11 new breast cancer cell lines

por Forozan, F, Veldman, R, Ammerman, C A, Parsa, N Z, Kallioniemi, A, Kallioniemi, O-P, Ethier, S P
Publicado 1999

Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.

por Hyytinen, E. R., Thalmann, G. N., Zhau, H. E., Karhu, R., Kallioniemi, O. P., Chung, L. W., Visakorpi, T.
Publicado 1997

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

por Mononen, N, Ikonen, T, Syrjäkoski, K, Matikainen, M, Schleutker, J, Tammela, T L J, Koivisto, P A, Kallioniemi, O P
Publicado 2001

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

por Rapakko, K, Allinen, M, Syrjäkoski, K, Vahteristo, P, Huusko, P, Vähäkangas, K, Eerola, H, Kainu, T, Kallioniemi, O-P, Nevanlinna, H, Winqvist, R
Publicado 2001

Germline TP53 mutations in Finnish breast cancer patients

por Rapakko, K, Allinen, M, Syrjäkoski, K, Vahteristo, P, Huusko, P, Vähäkangas, K, Eerola, H, Kainu, T, Kallioniemi, O-P, Nevanlinna, H, Winqvist, R
Publicado 2000

Molecular characteristics of inherited breast tumors

por Borg, Å, Hedenfalk, IA, Vallon-Christersson, J, Loman, N, Johannsson, O, Olsson, H, Duggan, DJ, Chen, Y, Bittner, M, Kallioniemi, O-P, Trent, JM
Publicado 2000

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

por Antoniou, A C, Cunningham, A P, Peto, J, Evans, D G, Lalloo, F, Narod, S A, Risch, H A, Eyfjord, J E, Hopper, J L, Southey, M C, Olsson, H, Johannsson, O, Borg, A, Passini, B, Radice, P, Manoukian, S, Eccles, D M, Tang, N, Olah, E, Anton-Culver, H, Warner, E, Lubinski, J, Gronwald, J, Gorski, B, Tryggvadottir, L, Syrjakoski, K, Kallioniemi, O-P, Eerola, H, Nevanlinna, H, Pharoah, P D P, Easton, D F
Publicado 2008

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

por Antoniou, A C, Cunningham, A P, Peto, J, Evans, D G, Lalloo, F, Narod, S A, Risch, H A, Eyfjord, J E, Hopper, J L, Southey, M C, Olsson, H, Johannsson, O, Borg, A, Pasini, B, Radice, P, Manoukian, S, Eccles, D M, Tang, N, Olah, E, Anton-Culver, H, Warner, E, Lubinski, J, Gronwald, J, Gorski, B, Tryggvadottir, L, Syrjakoski, K, Kallioniemi, O-P, Eerola, H, Nevanlinna, H, Pharoah, P D P, Easton, D F
Publicado 2008